NCT07341009

Brief Summary

Perceiving and representing the passage of time allows us to temporally organize perceptions and memories for the coordination of actions, planning, and the mobilization of cognitive processes toward a goal. This innovative project aims to clarify the profile of time impairment associated with normal aging and the progression of age-related pathologies. This project proposes to develop a new neuropsychological tool for quantifying and preventing changes in the relationship to time associated with Alzheimer's disease. Four aspects of time are distinguished, which are measured separately and distributed along a continuum between perception and memory: (a) perception of simultaneity and order; (b) processing of durations; (c) subjective sense of the passage of time; and (d) mental time travel. Crucially, many neurological and psychiatric disorders are associated with impairment in one or more aspects of time. However, time remains largely unexplored in clinical practice. Patients with Alzheimer's disease will complete the CHRONOS battery. This battery allows for a rapid assessment (approximately ten minutes) of the four aspects of time. This new battery will enable the identification of behavioral markers aimed at improving prognosis and prevention regarding individual cognitive trajectories of aging. The relationship to time is closely linked to each person's personal experience. This project will help to put into words difficulties that are not always expressed in terms of time. Thus, considering these pathologies from the perspective of time aims to better understand and prevent their difficulties and to guide the identification of new markers and new avenues for remediation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
18mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Dec 2025Nov 2027

First Submitted

Initial submission to the registry

December 12, 2025

Completed
18 days until next milestone

Study Start

First participant enrolled

December 30, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 14, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

March 19, 2026

Status Verified

October 1, 2025

Enrollment Period

1.8 years

First QC Date

December 12, 2025

Last Update Submit

March 17, 2026

Conditions

Keywords

temporal cognitiondementiacognitionneuropsychology

Outcome Measures

Primary Outcomes (1)

  • Behavioral difference at the battery assessing temporal processing (CHRONOS (Cognitive Health Ratings Of Neuropsychological Skills for temporal perception) Score /30 + subscores)

    From enrollment to the end of the neuropsychological assessment (three hours)

Study Arms (1)

Alzheimer's patients

Behavioral: Chronos battery

Interventions

Chronos batteryBEHAVIORAL

Patients will perform the battery during a neuropsychological assessment

Alzheimer's patients

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Alzheimer's disease

You may qualify if:

  • No objection from the participant or their legal representative, if applicable, prior to or during the assessment
  • Deficit in at least two cognitive functions, including episodic memory.

You may not qualify if:

  • History of head trauma with loss of consciousness lasting more than 1 hour
  • Presence of clinically significant major psychiatric disorders (according to DSM-IV-TR criteria)
  • Use of medications likely to alter cognitive and/or brain function (decision by the principal investigator)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Caen Hospital, neurology Unit

Caen, 14000, France

RECRUITING

MeSH Terms

Conditions

Alzheimer DiseaseDementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2025

First Posted

January 14, 2026

Study Start

December 30, 2025

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

March 19, 2026

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations